Medical News

RSS

Pfizer becomes the latest customer of Benchware Discovery 360

Tripos®, a leading provider of drug discovery informatics products and services, today announced that Pfizer has become the latest customer of Benchware® Discovery 360 (D360). The novel license agreement allows Pfizer to deploy the capabilities of D360 to all scientists within its worldwide research sites.

27 Jan 2010

Innovative Alaska Health Plan outperforms many others in lower 48

Kaiser Health News reports on Alaska's Southcentral Foundation.

27 Jan 2010

UCSB research: Rapamycin drug, a potential treatment for ADPKD

Research performed at UC Santa Barbara points to the drug rapamycin as a potential treatment for kidney disease. The study builds on past research and shows that studies performed on mice are more likely to translate to humans than previously thought.

27 Jan 2010

Lawmakers sound off on health bill: Pascrell, Mccain, Durbin, Hatch and Murphy

Rep. Bill Pascrell [D-N.J.] has called fellow Democrats 'arrogant' and referred to a key party talking point as 'BS.' He slammed deals cut by leadership and special interests and said, 'We're not going to accept that any longer.' Agitated and unfiltered, Pascrell has become the guy who's not afraid to go public with what many rank-and-file House Democrats have been saying behind closed doors.

27 Jan 2010

Preoperative CT may help reduce unnecessary surgeries in women with suspected acute appendicitis

Preoperative computed tomography (CT) may help reduce unnecessary surgeries in women of reproductive age with suspected acute appendicitis, according to a new study appearing in the February issue of the journal Radiology.

27 Jan 2010

Prometheus Laboratories executes commercialization agreement with Novartis

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the execution of a commercialization agreement with Novartis under which Prometheus acquired exclusive rights to distribute, promote and sell PROLEUKIN® (aldesleukin) in the United States.

27 Jan 2010

New U.S. patent broadens Cytori Therapeutics' portfolio covering adipose-derived cell therapies

Cytori Therapeutics today received U.S. Patent No. 7,651,684 (the ‘684 patent) which covers the Company’s methods for delivering adipose-derived stem and regenerative cell-enriched fat grafts into patients. The ‘684 patent specifically covers cell-enriched fat grafts to treat soft-tissue defects and urinary incontinence. In addition, the ‘684 patent covers methods for delivering cell-enriched fat grafts to a patient’s breast, wrinkles, lips, under the eyes, cheeks, chin, and other parts of the body.

27 Jan 2010

Book highlights causes and remedies for bad breath

So, you've bought the candy, the diamond necklace, made the reservations at her favorite restaurant and had your suit cleaned and pressed. Still, even if you earn that special Valentine's Day kiss, it won't make a difference if your breath is so bad that it could motivate the dog to leave the room.

27 Jan 2010

Massachusetts Department of Public Health grants WDL to Pharmarama

Pharmarama, a leader in the strategic sourcing of comparator drugs for global clinical trials, today announced that the Massachusetts Department of Public Health has granted the company a Wholesale Distributor’s License (WDL). The license enables Pharmarama to operate its pharmaceutical cold-chain and ambient storage and distribution facility in suburban Boston to provide extensive sourcing and comparator product storage services for its clients.

27 Jan 2010

EpiCept's NP-1 for treatment of PHN receives FDA orphan drug designation

EpiCept Corporation announced today that EpiCeptTM NP-1 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of post-herpetic neuralgia (PHN). NP-1 is a prescription topical analgesic cream designed to provide long-term relief from the pain of peripheral neuropathies.

27 Jan 2010

Report highlights challenges facing Obama in Africa

A new report highlights challenges facing the Obama administration in Africa, including HIV/AIDS, poverty and climate change, VOA News reports.

27 Jan 2010

Oxford Journals, IDSA sign new publishing partnership

Oxford Journals, a division of Oxford University Press, and the Infectious Diseases Society of America (IDSA), a leading professional society, have announced a new publishing partnership for IDSA's highly cited and internationally prestigious journals: Clinical Infectious Diseases (CID) and The Journal of Infectious Diseases (JID).

27 Jan 2010

Eating green leafy vegetables could reverse the effects of aflatoxin poisoning

Not only are the vitamins and minerals good for you, but eating greens could also save your life, according to a recent study led by the National Nuclear Security Administration's Lawrence Livermore National Laboratory scientists.

27 Jan 2010

Budget realities are rippling through states' health institutions

The (Raleigh, N.C.) News-Observer: "The state's drug assistance program for HIV patients has been capped at its current enrollment, with budget cuts hitting at the same time more people need help, state officials said Monday." Because patients with HIV are more likely to spread the virus when not on medications, public health officials are worried about denying medications (Avery, 1/26).

27 Jan 2010

Donors agree to 10-Year Haitian rebuilding effort amid concerns; no firm financial commitments

At a meeting in Montreal, Canada, on Monday, international donors noted concerns, but agreed to a 10-year reconstruction plan to rebuild Haiti, the New York Times reports. "Given Haiti's long history of mismanagement of funds, international donors were hesitant to write a blank check. And foreign governments had concerns as well about the government's ability to direct a large reconstruction project after most government buildings were flattened or severely damaged in the Jan. 12 quake," the newspaper writes (Lacey/Thompson, 1/25).

27 Jan 2010

dbMotion receives certification for IHE Profiles

dbMotion, a provider of health interoperability solutions, today announced it successfully completed interoperability testing at the 11th Annual IHE North American Connectathon in Chicago.

27 Jan 2010

FDA approves oral pain relief solution for opioid-tolerant patients

The U.S. Food and Drug Administration today approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and chronic pain in opioid-tolerant patients. This medicine will be available in 100 milligrams per 5 mL or 20 milligrams per 1 mL.

27 Jan 2010

GOP lawmaker set to release health care 'declaration'

Republicans are seeking consensus on health care now that Democrats can no longer go it alone, having lost their filibuster-proof 60-vote Senate majority, NPR reports. Senior Republicans are "shopping around" policy ideas they say everyone could agree with "off the bat," including a cap on certain malpractice damages and allowing insurers to sell plans across state lines. But, some observers note that even when they were in the majority, Republicans failed to agree even on those issues (Rovner, 1/26).

27 Jan 2010

Patients with COPD could benefit from treatment with drugs that block sestrin function

Chronic obstructive pulmonary disease (COPD) is defined by emphysema and/or chronic bronchitis. It destroys the normal architecture of the lung and inhibits the mechanical aspects of breathing, which prevents necessary gas exchange. Patients suffer from coughing fits, wheezing, and increased incidence of lung infections.

27 Jan 2010

Cornerstone Pharmaceuticals closes $6.17M Series B-4 private equity financing

Cornerstone Pharmaceuticals Inc., a privately held, clinical stage oncology-focused pharmaceutical company, has announced the closing of its Series B-4 private equity financing of $6,175,000. The Company plans to use the proceeds for its on-going phase I/II clinical trials of its lead cancer drug--CPI-613, research and development, and general corporate purposes.

27 Jan 2010